STMN2 and cancer: Given that several reports suggest that cancer progression is associated with aberrant MT dynamics and the expression of MT dynamics regulators expression, we propose that Prkd3 regulates the expression of the MT-associated proteins Stmn2 and Map10, favoring a proliferative phenotype in immortalized MEFs.